Exacerbation of interstitial lung disease during etanercept therapy: Two cases

Joint Bone Spine

Volumn 75, Issue 2, 2008, Pages 215-218

  Tournadre, Anne ^a   Ledoux Eberst, Julie ^a   Poujol, David ^a   Dubost, Jean Jacques ^a   Ristori, Jean Michel ^a   Soubrier, Martin ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Interstitial lung disease; Rheumatoid lung; TNF alpha antagonists

Indexed keywords

AMOXICILLIN; AZATHIOPRINE; ETANERCEPT; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; MOXIFLOXACIN; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; BLOOD GAS ANALYSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEVER; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; HUMAN; INTERSTITIAL LUNG DISEASE; INTERTITIAL LUNG DISEASE EXACERBATION; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; MONARTHRITIS; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; TUBERCULIN TEST;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOGLOBULIN G; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40949087174     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.04.028     Document Type: Article

References (21)

1. Turesson C., O'Fallon W.M., Crowson C.S., et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 62 (2003) 722-727
2. Allen J.T., and Spiteri M.A. Growth factors in idiopathic pulmonary fibrosis: relative roles. Respir Res 3 (2002) 13
3. Peno-Green L., Lluberas G., Kingsley T., et al. Lung injury linked to etanercept therapy. Chest 122 (2002) 1858-1860
4. Kramer N., Chuzhin Y., Kaufman L.D., et al. Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum 47 (2002) 670-671
5. Courtney P.A., Alderdice J., and Whitehead E.M. Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum 49 (2003) 617
6. Vavricka S.R., Wettstein T., Speich R., et al. Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy. Thorax 58 (2003) 278-279
7. Chatterjee S. Severe interstitial pneumonitis associated with infliximab therapy. Scan J Rheumatol 33 (2004) 276
8. Yousem S.A., and Dacic S. Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy. Mod Pathol 18 (2005) 651-655
9. Schoe A., van der Laan-Baalbergen N.E., Huizinga T.W., et al. Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab. Arthritis Rheum 55 (2006) 157-159
10. Phillips K., and Weinblatt M. Granulomatous lung disease occurring during etanercept treatment. Arthritis Rheum 53 (2005) 618-620
11. Ostor A.J., Chilvers E.R., Somerville M.F., et al. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. J Rheumatol 33 (2006) 622-628
12. Villeneuve E., St-Pierre A., and Haraoui B. Interstitial pneumonitis associated with infliximab therapy. J Rheumatol 33 (2006) 1189-1193
13. Takeishi M., Akiyama Y., Akiba H., et al. Leflunomide induced acute interstitial pneumonia. J Rheumatol 32 (2005) 1160-1163
14. Parry S.D., Barbatzas C., Peel E.T., et al. Sulphasalazine and lung toxicity. Eur Respir J 19 (2002) 756-764
15. Anaya J.M., Diethelm L., Ortiz L.A., et al. Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 24 (1995) 242-254
16. Weatherhead M., Masson S., Bourke S.J., et al. Interstitial pneumonitis after infliximab therapy for Crohn's disease. Inflamm Bowel Dis 12 (2006) 427-428
17. Allanore Y., Devos-Francois G., Caramella C., et al. Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab. Ann Rheum Dis 65 (2006) 834-835
18. Bargagli E., Galeazzi M., and Rottoli P. Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis. Eur Respir J 24 (2004) 708
19. Gosset P., Perez T., Lassalle P., et al. Increased TNF-alpha secretion by alveolar macrophages from patients with rheumatoid arthritis. Am Rev Respir Dis 143 (1991) 593-597
20. Saint-Marcoux B., and de Bandt M. Vasculitides induced by TNFα antagonists: a study in 39 patients in France. Joint Bone Spine 73 (2006) 710-713
21. Brocq O., Roux C.H., Albert C., et al. TNFα antagonist continuation rates in 442 patients with inflammatory joint disease. Joint Bone Spine 74 (2007) 148-154